Temozolomide may induce therapy-related acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 154, Issue 5, 2011, Pages 663-665

  Ogura, Mizuki ^a   Todo, Tomoki ^a,b   Tanaka, Minoru ^a   Nannya, Yasuhito ^a   Ichikawa, Motoshi ^a   Nakamura, Fumihiko ^a   Kurokawa, Mineo ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Acute lymphoblastic leukaemia; Alkylating agent; Glioblastoma; Temozolomide; Therapy related

Indexed keywords

ASPARAGINASE; CD19 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; PREDNISOLONE; TEMOZOLOMIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ASTROCYTOMA; BONE MARROW BIOPSY; CANCER GRADING; CASE REPORT; CRANIOTOMY; DETERIORATION; DISEASE PREDISPOSITION; DRUG DOSE INCREASE; DRUG EXPOSURE; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GLIOBLASTOMA; HEMIPARESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE; LETTER; LEUKEMIA REMISSION; LEUKOPENIA; MALIGNANT TRANSFORMATION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; REOPERATION; SKULL IRRADIATION; TREATMENT DURATION; TUMOR BLEEDING;

ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; GLIOMA; HUMANS; NEOPLASMS, SECOND PRIMARY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 80051599182     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08641.x     Document Type: Letter

References (10)

1. Brada, M., Stenning, S., Gabe, R., Thompson, L.C., Levy, D., Rampling, R., Erridge, S., Saran, F., Gattamaneni, R., Hopkins, K., Beall, S., Collins, V.P. & Lee, S.M. (2010) Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma. Journal of Clinical Oncology, 28, 4601-4608.
2. De Vita, S., De Matteis, S., Laurenti, L., Chiusolo, P., Reddiconto, G., Fiorini, A., Leone, G. & Sica, S. (2005) Secondary Ph+ acute lymphoblastic leukemia after temozolomide. Annals of Hematology, 84, 760-762.
3. Löning, L., Zimmermann, M., Reiter, A., Kaatsch, P., Henze, G., Riehm, H. & Schrappe, M. (2000) Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood, 95, 2770-2775.
4. Mauritzson, N., Albin, M., Rylander, L., Billström, R., Ahlgren, T., Mikoczy, Z., Björk, J., Strömberg, U., Nilsson, P.G., Mitelman, F., Hagmar, L. & Johansson, B. (2002) Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia, 16, 2366-2378.
5. Momota, H., Narita, Y., Miyakita, Y., Hosono, A., Makimoto, A. & Shibui, S. (2010) Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation. Pediatric Blood & Cancer, 55, 577-579.
6. Pagano, L., Pulsoni, A., Tosti, M.E., Annino, L., Mele, A., Camera, A., Martino, B., Guglielmi, C., Cerri, R., Di Bona, E., Invernizzi, R., Castagnola, C., Bassan, R., Mele, L., Todeschini, G., Leone, G. & Mandelli, F. (1999) Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Brirish Journal of Haematology, 106, 1037-1040.
7. Perry, J.R., Brown, M.T. & Gockerman, J.P. (1998) Acute leukemia following treatment of malignant glioma. Journal of Neuro-Oncology, 40, 39-46.
8. Shaikh, A.J. & Masood, N. (2010) Acute lymphoblastic leukemia subsequent to temozolomide use in a 26-year-old man: a case report. Journal of Medical Case Reports, 4, 274.
9. Shivakumar, R., Tan, W., Wilding, G.E., Wang, E.S. & Wetzler, M. (2008) Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases. Annals of Oncology, 19, 1634-1638.
10. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J.B., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R.C., Ludwin, S.K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J.G., Eisenhauer, E. & Mirimanoff, R.O., European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 352, 987-996.